Description

Infragyl Spag peca oral drops 30 ml. vial

Ingredients

Infragyl Spag peca oral drops contain active ingredient Metronidazole, which is an antibiotic that fights bacteria in the body.

Dosage

The recommended dosage of Infragyl Spag peca oral drops is determined by the healthcare provider based on the condition being treated. It is crucial to follow the prescribed dosage and duration.

Indications

Infragyl Spag peca oral drops are indicated for the treatment of bacterial infections, including certain types of vaginal infections and skin infections.

Contraindications

Do not use Infragyl Spag peca oral drops if you are allergic to metronidazole or any other ingredients in the product. It is important to inform your healthcare provider about any allergies or medical conditions before starting this medication.

Directions

Shake the vial well before use. Take the prescribed amount of drops orally as directed by your healthcare provider. Do not exceed the recommended dosage.

Scientific Evidence

Studies have shown that metronidazole, the active ingredient in Infragyl Spag peca oral drops, is effective in treating various bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy highlighted the efficacy of metronidazole in the treatment of anaerobic infections.

Additional Information

It is important to complete the full course of treatment with Infragyl Spag peca oral drops as prescribed, even if symptoms improve before the medication is finished. Failure to complete the full course may result in the infection not being fully treated.

Metronidazole, the active ingredient in Infragyl Spag peca oral drops, works by entering bacterial cells and interfering with their DNA, ultimately leading to the death of the bacteria. This antibiotic is particularly effective against anaerobic bacteria, which thrive in low oxygen environments.

Clinical trials have demonstrated the efficacy of metronidazole in treating a wide range of infections, from gastrointestinal to gynecological infections. In a study published in the International Journal of Antimicrobial Agents, metronidazole was found to be highly effective in the treatment of Clostridium difficile infections.